Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930413-06-001567
Filing Date
2006-03-01
Accepted
2006-02-28 21:25:00
Documents
17
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 c40966_10k.htm 10-K 191941
2 c40966_ex10-17.htm EX-10.17 10178
3 c40966_ex10-20.htm EX-10.20 3067
4 c40966_ex12.htm EX-12 15673
5 c40966_ex13.htm EX-13 2401096
6 GRAPHIC c40915002.gif GRAPHIC 14581
7 GRAPHIC c40915003.jpg GRAPHIC 6381
8 GRAPHIC c40915004.jpg GRAPHIC 6516
9 GRAPHIC c40915005.jpg GRAPHIC 8080
10 GRAPHIC c40915006.jpg GRAPHIC 11948
11 GRAPHIC c40915007.jpg GRAPHIC 4078
12 c40966_ex21.htm EX-21 97386
13 c40966_ex23.htm EX-23 4458
14 c40966_ex31-1.htm EX-31.1 4603
15 c40966_ex31-2.htm EX-31.2 4588
16 c40966_ex32-1.htm EX-32.1 2000
17 c40966_ex32-2.htm EX-32.2 1985
  Complete submission text file 0000930413-06-001567.txt   2810355
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-03619 | Film No.: 06652972
SIC: 2834 Pharmaceutical Preparations